<div class="xblock xblock-public_view xblock-public_view-vertical" data-has-score="False" data-block-type="vertical" data-request-token="95c19bd884be11ef87a412578eed8dbf" data-usage-id="block-v1:MITx+15.480x+3T2021+type@vertical+block@809b189418d940edb9a372d3027e4f82" data-init="VerticalStudentView" data-runtime-class="LmsRuntime" data-runtime-version="1" data-graded="False" data-course-id="course-v1:MITx+15.480x+3T2021">
<h2 class="hd hd-2 unit-title">This course on Open Learning Library</h2>
<div class="vert-mod">
<div class="vert vert-0" data-id="block-v1:MITx+15.480x+3T2021+type@html+block@fa232e94b50d44109bd8a8f637b4e238">
<div class="xblock xblock-public_view xblock-public_view-html xmodule_display xmodule_HtmlBlock" data-has-score="False" data-block-type="html" data-request-token="95c19bd884be11ef87a412578eed8dbf" data-usage-id="block-v1:MITx+15.480x+3T2021+type@html+block@fa232e94b50d44109bd8a8f637b4e238" data-init="XBlockToXModuleShim" data-runtime-class="LmsRuntime" data-runtime-version="1" data-graded="False" data-course-id="course-v1:MITx+15.480x+3T2021">
<script type="json/xblock-args" class="xblock-json-init-args">
{"xmodule-type": "HTMLModule"}
</script>
<p style="text-rendering: optimizelegibility; margin-top: 0px; margin-right: 0px; margin-left: 0px; padding: 0px; border: 0px; outline: 0px; font-variant-numeric: inherit; font-variant-east-asian: inherit; font-stretch: inherit; font-family: 'Open Sans', 'Helvetica Neue', Helvetica, Arial, sans-serif; font-size: 16px; vertical-align: baseline; color: #313131;"><span style="color: rgb(49, 49, 49); font-family: "Open Sans", "Helvetica Neue", Helvetica, Arial, sans-serif; font-size: 16px;">In this version of </span><font color="#313131" face="Open Sans, Helvetica Neue, Helvetica, Arial, sans-serif"><i>The Science and </i></font><font color="#313131" face="Open Sans, Helvetica Neue, Helvetica, Arial, sans-serif"><i>Business of Biotechnology</i></font><span style="color: rgb(49, 49, 49); font-family: "Open Sans", "Helvetica Neue", Helvetica, Arial, sans-serif; font-size: 16px;"> on Open Learning Library:</span></p>
<ul style="text-rendering: optimizelegibility; border: 0px; outline: 0px; font-variant-numeric: inherit; font-variant-east-asian: inherit; font-stretch: inherit; line-height: 1.4em; font-family: 'Open Sans', 'Helvetica Neue', Helvetica, Arial, sans-serif; vertical-align: baseline; color: #313131;">
<li style="text-rendering: optimizelegibility; margin-top: 0px; margin-right: 0px; margin-left: 0px; padding: 0px; border: 0px; outline: 0px; font-style: inherit; font-variant: inherit; font-weight: inherit; font-stretch: inherit; line-height: 1.4em; font-family: inherit; vertical-align: baseline;">No certificates can be earned on Open Learning Library</li>
<li style="text-rendering: optimizelegibility; margin-top: 0px; margin-right: 0px; margin-left: 0px; padding: 0px; border: 0px; outline: 0px; font-style: inherit; font-variant: inherit; font-weight: inherit; font-stretch: inherit; line-height: 1.4em; font-family: inherit; vertical-align: baseline;">Runs as ‘self-paced’ and all dates mentioned within are irrelevant</li>
<li style="text-rendering: optimizelegibility; margin-top: 0px; margin-right: 0px; margin-left: 0px; padding: 0px; border: 0px; outline: 0px; font-style: inherit; font-variant: inherit; font-weight: inherit; font-stretch: inherit; line-height: 1.4em; font-family: inherit; vertical-align: baseline;">Some assessment material may have been removed and grading adjusted accordingly</li>
<li style="text-rendering: optimizelegibility; margin-top: 0px; margin-right: 0px; margin-left: 0px; padding: 0px; border: 0px; outline: 0px; font-style: inherit; font-variant: inherit; font-weight: inherit; font-stretch: inherit; line-height: 1.4em; font-family: inherit; vertical-align: baseline;">Any discussion forums have been removed</li>
<li style="text-rendering: optimizelegibility; margin-top: 0px; margin-right: 0px; margin-left: 0px; padding: 0px; border: 0px; outline: 0px; font-style: inherit; font-variant: inherit; font-weight: inherit; font-stretch: inherit; line-height: 1.4em; font-family: inherit; vertical-align: baseline;">All assessments have been set to unlimited attempts</li>
<li style="text-rendering: optimizelegibility; margin-top: 0px; margin-right: 0px; margin-left: 0px; padding: 0px; border: 0px; outline: 0px; font-style: inherit; font-variant: inherit; font-weight: inherit; font-stretch: inherit; line-height: 1.4em; font-family: inherit; vertical-align: baseline;">Some course content may have been removed </li>
</ul>
<p></p>
</div>
</div>
</div>
</div>
<div class="xblock xblock-public_view xblock-public_view-vertical" data-has-score="False" data-block-type="vertical" data-request-token="95c19bd884be11ef87a412578eed8dbf" data-usage-id="block-v1:MITx+15.480x+3T2021+type@vertical+block@217589399dd841188f5b22782031b522" data-init="VerticalStudentView" data-runtime-class="LmsRuntime" data-runtime-version="1" data-graded="False" data-course-id="course-v1:MITx+15.480x+3T2021">
<h2 class="hd hd-2 unit-title">Syllabus and Course Schedule</h2>
<div class="vert-mod">
<div class="vert vert-0" data-id="block-v1:MITx+15.480x+3T2021+type@html+block@b0ea88bb21974d36b5aeab87f4797d80">
<div class="xblock xblock-public_view xblock-public_view-html xmodule_display xmodule_HtmlBlock" data-has-score="False" data-block-type="html" data-request-token="95c19bd884be11ef87a412578eed8dbf" data-usage-id="block-v1:MITx+15.480x+3T2021+type@html+block@b0ea88bb21974d36b5aeab87f4797d80" data-init="XBlockToXModuleShim" data-runtime-class="LmsRuntime" data-runtime-version="1" data-graded="False" data-course-id="course-v1:MITx+15.480x+3T2021">
<script type="json/xblock-args" class="xblock-json-init-args">
{"xmodule-type": "HTMLModule"}
</script>
<p><strong>Week 0:</strong></p>
<ul>
<ul>
<ul>
<ul>
<li>Syllabus and Calendar</li>
<li>Homework, Discussion, and Collaboration Guidelines</li>
</ul>
</ul>
</ul>
</ul>
<p style="padding-left: 30px;"><strong>Unit 0a: Introduction to Healthcare Finance</strong></p>
<ul>
<ul>
<ul>
<ul>
<li>Lecture: Current Challenges in Healthcare Finance</li>
<li>Lecture: Biomedical Megafund FAQs</li>
</ul>
</ul>
</ul>
</ul>
<p style="font-size: 16px; padding-left: 30px;"><strong>Unit 0b: Introduction to the Science of Biotechnology</strong></p>
<ul style="padding-left: 30px;">
<ul>
<ul>
<li>Lecture: Drug Development</li>
<li>Biology Background Slides</li>
</ul>
</ul>
</ul>
<p style="font-size: 16px;"><strong>Week 1:</strong></p>
<p style="font-size: 16px; padding-left: 30px;"><strong>Unit 1a: Therapeutic Recombinant Proteins</strong></p>
<ul style="padding-left: 30px;">
<ul>
<ul>
<li>Lecture: Recombinant Therapeutic Proteins</li>
<li><span style="text-decoration: line-through;"><span style="color: #ff0000;">Problem Set 1a</span></span></li>
</ul>
</ul>
</ul>
<p style="padding-left: 30px;"><strong>Unit 1b: </strong><strong> Present Value</strong></p>
<ul>
<ul>
<ul>
<ul>
<li>Lecture: Market Efficiency, the Wisdom of Crowds, and the Madness of Mobs</li>
<li>Lecture: Time Value of Money and Drug Pricing Examples</li>
<li>Lecture: Buying Cures vs. Renting Health</li>
<li>Lecture: Inflation</li>
<li>Solved Practice Problems</li>
<li><span style="text-decoration: line-through;"><span style="color: #ff0000;">Problem Set 1b</span></span></li>
</ul>
</ul>
</ul>
</ul>
<p style="font-size: 16px;"><strong>Week 2:</strong></p>
<p style="padding-left: 30px;"><strong>Unit 2a: AAV Vectors & In Vivo Gene Therapy</strong></p>
<ul>
<ul>
<ul>
<ul>
<li>Lecture: Adeno Associated Viral (AAV) Vectors</li>
<li>Lecture: In Vivo Gene Therapy</li>
<li><span style="text-decoration: line-through;"><span style="color: #ff0000;">Problem Set 2a</span></span></li>
</ul>
</ul>
</ul>
</ul>
<p style="font-size: 16px; padding-left: 30px;"><strong>Unit 2b: </strong><strong>Capital Budgeting</strong></p>
<ul style="padding-left: 30px;">
<ul>
<ul>
<li>Lecture: Cash Flows, NPV, and IRR</li>
<li>Lecture: Genetech and Herceptin Funding Example</li>
<li>Solved Practice Problems</li>
<li><span style="text-decoration: line-through;"><span style="color: #ff0000;">Problem Set 2b</span></span></li>
</ul>
</ul>
</ul>
<p style="font-size: 16px;"><strong>Week 3:</strong></p>
<p style="padding-left: 30px;"><strong>Unit 3a: Ex-Vivo Gene Therapy</strong></p>
<ul>
<ul>
<ul>
<ul>
<li>Lecture: Retroviral & Lentiviral Vectors</li>
<li>Lecture: Application to Two Major Red Cell Disorders</li>
<li><span style="text-decoration: line-through;"><span style="color: #ff0000;">Problem Set 3a</span></span></li>
</ul>
</ul>
</ul>
</ul>
<p style="font-size: 16px; padding-left: 30px;"><strong>Unit 3b: </strong><strong>Stocks and Bonds</strong></p>
<ul style="padding-left: 30px;">
<ul>
<ul>
<li>Lecture: Stocks and Bonds</li>
<li>Solved Practice Problems</li>
<li><span style="text-decoration: line-through;"><span style="color: #ff0000;">Problem Set 3b</span></span></li>
</ul>
</ul>
</ul>
<p style="font-size: 16px;"><strong>Week 4:</strong></p>
<p style="padding-left: 30px;"><strong>Unit 4a: Nucleic Acid Therapies</strong></p>
<ul>
<ul>
<ul>
<ul>
<li>Lecture: Oligonucleotides Affecting Splicing of pre-mRNA</li>
<li>Lecture: shRNAs Causing Degradation of Target mRNAs</li>
<li><span style="text-decoration: line-through;"><span style="caret-color: #ff0000; color: #ff0000;">Problem Set 4a</span></span></li>
</ul>
</ul>
</ul>
</ul>
<p style="font-size: 16px; padding-left: 30px;"><strong>Unit 4b: </strong><strong>The CAPM & Diversification</strong></p>
<ul style="padding-left: 30px;">
<ul>
<ul>
<li>Lecture: Volatility, Risk and Uncertainty</li>
<li>Lecture: The CAPM</li>
<li>Lecture: Portfolio Theory</li>
<li>Lecture: Portfolio Theory in a Biomedical Context</li>
<li>Solved Practice Problems</li>
<li><span style="text-decoration: line-through;"><span style="color: #ff0000;">Problem Set 4b</span></span></li>
</ul>
</ul>
</ul>
<p style="font-size: 16px;"><strong>Week 5:</strong></p>
<p style="padding-left: 30px;"><strong>Unit 5a: Gene Editing</strong></p>
<ul>
<ul>
<ul>
<ul>
<li>Lecture: ZFNs and TALENs</li>
<li>Lecture: CRISPR</li>
<li><span style="text-decoration: line-through;"><span style="caret-color: #ff0000; color: #ff0000;">Problem Set 5a</span></span></li>
</ul>
</ul>
</ul>
</ul>
<p style="font-size: 16px; padding-left: 30px;"><strong>Unit 5b: Options</strong></p>
<ul style="padding-left: 30px;">
<ul>
<ul>
<li>Lecture: Option Pricing Theory</li>
<li>Lecture: Real Options and Biomedical Examples</li>
<li>Lecture: Monte Carlo Simulations</li>
<li>Solved Practice Problems</li>
<li><span style="text-decoration: line-through;"><span style="color: #ff0000;">Problem Set 5b</span></span></li>
</ul>
</ul>
</ul>
<p style="font-size: 16px;"><strong>Week 6:</strong></p>
<p style="padding-left: 30px;"><strong>Unit 6: </strong><strong>Clinical Trials</strong></p>
<ul>
<ul>
<ul>
<ul>
<li>Lecture: Drug Development & Clinical Trials</li>
<li>Lecture: Statistical Framework for Clinical Trials</li>
<li>Lecture: Bayesian Adaptive Clinical Trials</li>
<li><span style="text-decoration: line-through;"><span style="color: #ff0000;">Problem Set 6</span></span></li>
</ul>
</ul>
</ul>
</ul>
<p style="font-size: 16px;"><strong>Week 7:</strong></p>
<p style="padding-left: 30px;"><strong>Unit 7a: Antibody Generation</strong></p>
<ul>
<ul>
<ul>
<ul>
<li>Lecture: Vaccines, Antibodies, and Antibody Generation</li>
<li><span style="text-decoration: line-through;"><span style="color: #ff0000;">Problem Set 7a</span></span></li>
</ul>
</ul>
</ul>
</ul>
<p style="font-size: 16px; padding-left: 30px;"><strong>Unit 7b: </strong><strong>Venture Capital & New Business Models</strong></p>
<ul style="padding-left: 30px;">
<ul>
<ul>
<li>Lecture: Financing a Start-Up</li>
<li>Lecture: Valuation</li>
<li><span style="text-decoration: line-through;"><span style="color: #ff0000;">Problem Set 7b</span></span></li>
</ul>
</ul>
</ul>
<p style="font-size: 16px;"><strong>Week 8:</strong></p>
<p style="padding-left: 30px;"><strong>Unit 8a: Monoclonal Antibodies</strong></p>
<ul>
<ul>
<ul>
<ul>
<li>Lecture: Monoclonal Antibodies</li>
<li><span style="text-decoration: line-through;"><span style="caret-color: #ff0000; color: #ff0000;">Problem Set 8a</span></span></li>
</ul>
</ul>
</ul>
</ul>
<p style="font-size: 16px; padding-left: 30px;"><strong>Unit 8b: Securitization</strong></p>
<ul style="padding-left: 30px;">
<ul>
<ul>
<li>Lecture: The Financial Crisis & Securitization</li>
<li>Lecture: Megafunds & Their Limits</li>
<li><span style="text-decoration: line-through;"><span style="color: #ff0000;">Problem Set 8b</span></span></li>
</ul>
</ul>
</ul>
<p style="font-size: 16px;"><strong>Week 9:</strong></p>
<p style="padding-left: 30px;"><strong>Unit 9a: Cancer Immunotherapeutics</strong></p>
<ul>
<ul>
<ul>
<ul>
<li>Lecture: Immunotherapeutics for Cancers</li>
<li><span style="text-decoration: line-through;"><span style="color: #ff0000;">Problem Set 9a</span></span></li>
</ul>
</ul>
</ul>
</ul>
<p style="font-size: 16px; padding-left: 30px;"><strong>Unit 9b: </strong><strong>Healthcare Analytics</strong></p>
<ul style="padding-left: 30px;">
<ul>
<ul>
<li>Lecture: Risk and Return in the Biopharma Industries</li>
<li>Lecture: Clinical Trial Success Rates</li>
<li>Lecture: Predictive Analytics for Drug Approvals and Clinical-Phase Transitions</li>
<li>Lecture: Bayesian Decision Analysis for Randomized Clinical Trials</li>
<li><span style="text-decoration: line-through;"><span style="color: #ff0000;">Problem Set 9b</span></span></li>
</ul>
</ul>
</ul>
<p style="font-size: 16px;"><strong>Week 10:</strong></p>
<p style="padding-left: 30px;"><strong>Unit 10a: New Cell Therapies</strong></p>
<ul>
<ul>
<ul>
<ul>
<li>Lecture: ES Cells & iPS Cells</li>
<li>Lecture: Engineered Red Blood Cells (Rubius)</li>
<li><span style="text-decoration: line-through;"><span style="color: #ff0000;">Problem Set 10a</span></span></li>
</ul>
</ul>
</ul>
</ul>
<p style="font-size: 16px; padding-left: 30px;"><strong>Unit 10b: </strong><strong>Pricing, Value, and Ethics</strong></p>
<ul style="padding-left: 30px;">
<ul>
<ul>
<li>Lecture: Pricing, Value, and Ethics</li>
<li>Lecture: Pricing Issues</li>
<li>Lecture: Value vs Price</li>
</ul>
</ul>
</ul>
<p><strong>Final Exam</strong></p>
<ul>
<ul>
<ul>
<li><span style="text-decoration: line-through;"><span style="color: #ff0000;">Final Exam (Released March 1st, to be completed at your own pace!)</span></span></li>
</ul>
</ul>
</ul>
</div>
</div>
</div>
</div>
© All Rights Reserved